Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $11.53 as of April 18, 2026, representing a 2.62% decline in its most recent trading session. This analysis breaks down recent market context for the clinical-stage biotech stock, key technical support and resistance levels, and potential near-term price scenarios for investors monitoring the name. No recent earnings data is available for PMN as of this analysis, so recent price action has been driven primarily by technical flows a
ProMIS (PMN) Stock: Is It Overpriced in Market (Drifts Lower) 2026-04-18 - Community Chart Signals
PMN - Stock Analysis
3231 Comments
920 Likes
1
Nayma
Loyal User
2 hours ago
I read this and now I’m confused but calm.
👍 175
Reply
2
Kalaina
Loyal User
5 hours ago
The market demonstrates steady upward movement, with technical support levels intact. Intraday fluctuations remain moderate, indicating balanced investor behavior. Momentum metrics suggest continuation potential.
👍 283
Reply
3
Nezha
Community Member
1 day ago
Investor behavior indicates attention to both macroeconomic factors and individual stock fundamentals.
👍 264
Reply
4
Rasheem
Insight Reader
1 day ago
This feels like something is off but I can’t prove it.
👍 32
Reply
5
Bhargav
Insight Reader
2 days ago
I don’t get it, but I trust it.
👍 158
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.